| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/20/2008 | US7375112 Compounds and methods for regulating triglyceride levels |
| 05/20/2008 | US7375111 Compositions for affecting weight loss |
| 05/20/2008 | US7375110 Nicotinic cholinergic receptors modulators; pain, neurodegenerative diseases; neurotransmission dysfuctions; central and autonomic nervous systems disorders; 1'-(3-pyridyl)-spiro[1-azabicyclo[2.2.1]heptane-2,3'-pyrrolidine] |
| 05/20/2008 | US7375109 Glycine-substituted thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity |
| 05/20/2008 | US7375107 Alaphatic pyrazinoylguanidine sodium channel blockers |
| 05/20/2008 | US7375106 Analgesic; Ketorolac or indomethacin nsaid with an opioid diarylmethyl piperazine such as 3-[( alpha R)- alpha -((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl]-N-(3-fluorophenyl)-N-methylbenzamide; dosage of the opioid can be decreased so side effects are reduced |
| 05/20/2008 | US7375105 Neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine, cardiac hypertrophy |
| 05/20/2008 | US7375104 Long acting beta-2-agonists and their use as medicaments |
| 05/20/2008 | US7375103 (-)-7-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-5-[(3S)-3-piperidinyl]-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one or salt as I kappa-B kinase inhibitor; antiinflammatory agent; autoimmune diseases, ischemia, cancer |
| 05/20/2008 | US7375102 inflammatory diseases, immune disorders, multiple sclerosis, rheumatoid arthritis, psoriasis; CXCR3 chemokine receptor modulators; 2-(4-fluoro-3-trifluoromethyl-phenyl)-N-(2-methanesulfonyl-ethyl)-N-(1-{4-oxo-3-[4-(2,2,2-trifluoro-ethoxy)-phenyl]-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl}-ethyl)-acetamide |
| 05/20/2008 | US7375101 N-(7-chloro-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-N'-(5isoquinolinyl)-thiourea; bradykinin receptor B2 antagonists;analgesic; septic shock, pancreatitis, edema, rhinitis, asthma, colitis, arthritis, hepatorenal syndrome, cancer, bacterial and viral infections, ulcerative colitis |
| 05/20/2008 | US7375100 2-amino-pyridine derivatives useful for the treatment of diseases |
| 05/20/2008 | US7375099 Malonamide derivatives |
| 05/20/2008 | US7375098 8β-vinyl-11β-(ω-substituted)alkyl-estra-1,3,5(10)-trienes |
| 05/20/2008 | US7375097 Increasing ATP availability by inhibition of creatine kinase (CK) leakage resulting from high-intensity exercise |
| 05/20/2008 | US7375096 Method of preparing a supramolecular complex containing a therapeutic agent and a multi-dimensional polymer network |
| 05/20/2008 | US7375095 Sugar derivative |
| 05/20/2008 | US7375094 Produced via Streptomyces; antitumor agents; time-release agents; for opiod-resistant pain; drug screening |
| 05/20/2008 | US7375093 Nuclear receptor-based inducible gene expression system |
| 05/20/2008 | US7375092 Blocking mitosis; transfection nucleic acid; anticancer agents |
| 05/20/2008 | US7375090 inhibitory effect on sodium-dependent glucose cotransporter; for the treatment of diseases, particularly metabolic disorders such as diabetes; e.g. 1-(2-propyn-1-yl)-3-( beta -D-glucopyranosyloxy)-4-(4-ethylbenzyl)-5-methyl-1H-pyrazole |
| 05/20/2008 | US7375089 Rehydration composition |
| 05/20/2008 | US7375088 culture product from a Streptomyces aizunensis strain; inhibitors of fungal cell growth and cancer cell growth; for lowering serum cholesterol and other steroids |
| 05/20/2008 | US7375087 prevention or treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. 4-[(4-{3-[1-carbamoyl-1-(methyl)-ethylcarbamoyl]propyl}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole |
| 05/20/2008 | US7375083 Pharmaceutical compositions for prevention of overdose or abuse |
| 05/20/2008 | US7375082 Administering composition comprising hydrocodone covalently bound to a single amino acid or an oligopeptide of 15 or fewer amino acids through the N-terminus or side chain of oligopeptide or amino acid; decreasing the bioavailability by intravenous or intranasal administration |
| 05/20/2008 | US7375081 Synergist mixture with lipopeptide and cyclic hexapeptide |
| 05/20/2008 | US7375078 for linking drug moieties to ligands; comprises a peptide sequence that is a substrate for an intracellular enzyme, for example a cathepsin, that cleaves the peptide at an amide bond |
| 05/20/2008 | US7375064 Functionalized polymeric surfactants based upon alkyl polyglycosides |
| 05/20/2008 | US7374931 Vaccine against staphylococcus intoxication |
| 05/20/2008 | US7374915 Using 1,4-dihysdroxy-2-naphthoic acid as additive in foods and beverages improving intestinal flora and alleviating abdominal ailments caused by lactose intolerance; for prevention or treatment of metabolic bone disorders |
| 05/20/2008 | US7374909 mediated by receptors of the TNF/NGF superfamily of receptors; originally designated CBK, but now designated B1; DNA sequence: vector |
| 05/20/2008 | US7374783 high skin care effect and a high anti-aging effect; N-acyl derivatives of proline, hydroxyproline, alanine, glycine, sarcosine, aspartic acid and glutamic acid with C12-C22 fatty acid; N-lauroylglycine, N-lauroylglutamic acid, dipalmitoylhydroxyproline, N-myristoylalanine, N-palmitoylaspartic acid |
| 05/20/2008 | US7374782 Inhaler; supplying therapy to lungs |
| 05/20/2008 | US7374781 Sustained release formulations containing acetaminophen and tramadol |
| 05/20/2008 | US7374779 Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
| 05/20/2008 | US7374778 Enhanced transport using membrane disruptive agents |
| 05/20/2008 | US7374772 A mixture comprising triacetin, tolnaftate fungicide and synthetic vitamin A, for treating skin and nail infections, treating patients with immune compromised, or with diabetes, even healthy person |
| 05/20/2008 | US7374770 Topical applying decarboxylase inhibitor |
| 05/20/2008 | US7374760 Methods and compositions for nerve regeneration |
| 05/20/2008 | US7374754 Administering topical or by injection; regenerating strength, thickness of aging skins |
| 05/20/2008 | US7374748 phospholipid complexes of flavanolignanes extracted from Silybum marianum; phospholipid complexes of Vitis vinifera standardized extract and phospholipid complexes of triterpenes extracted from Glycyrrhiza glabra |
| 05/20/2008 | US7374747 topical delivery of a quick-breaking temperature sensitive foam antibacterial composition to the skin; clindamycin phosphate and a foaming agent comprising an C1-C6 alcohol, a C14-C22 alcohol, a surfactant, water, aerosol propellant; dispensed from pressurized container; acne |
| 05/20/2008 | US7374570 Polymer compositions for intraluminal stent |
| 05/20/2008 | CA2569080A1 Anti-coronavirus molecules and their use in compositions and methods for treating and/or preventing infection caused by a coronavirus |
| 05/20/2008 | CA2499546C Sustained released delivery of amphetamine salts |
| 05/20/2008 | CA2453123C Intermediate for condensed benzazepine derivatives |
| 05/20/2008 | CA2438218C Modulated release particles for aerosol delivery |
| 05/20/2008 | CA2432223C Pyrazole compounds useful as protein kinase inhibitors |
| 05/20/2008 | CA2430065C Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents |
| 05/20/2008 | CA2416976C Treatment of estrogen receptor positive carcinoma with a rapamycin and an antiestrogen |
| 05/20/2008 | CA2415681C Pyrrolidine derivatives |
| 05/20/2008 | CA2395717C Fused imidazolium derivatives |
| 05/20/2008 | CA2385440C 5-hydroxysapogenin derivatives with anti-dementia activity |
| 05/20/2008 | CA2385410C Sapogenin derivatives and their use in the treatment of cognitive dysfunction |
| 05/20/2008 | CA2366862C Transdermal therapeutic system and process for its production |
| 05/20/2008 | CA2359008C Triazolo-pyridazine derivatives as ligands for gaba receptors |
| 05/20/2008 | CA2350801C Hiv replication inhibiting pyrimidines |
| 05/20/2008 | CA2344308C Taurolidine and/or taurultam against infectious ulcer or gastritis |
| 05/20/2008 | CA2333668C 17.beta.-nitro-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 05/20/2008 | CA2331333C Antisense oligonucleotide constructs based on .beta.-arabinofuranose and its analogues |
| 05/20/2008 | CA2322862C 20-keto-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 05/20/2008 | CA2322309C Quinolin-4-yl derivatives |
| 05/20/2008 | CA2317465C Synthetic polysaccharides, their method of production and pharmaceutical compositions containing same |
| 05/20/2008 | CA2309256C Chemical synthesis of 6-o-alkyl erythromycin a |
| 05/20/2008 | CA2309255C Process for n-desmethylating erythromycins and derivatives thereof |
| 05/20/2008 | CA2307788C 2-halo-6-o-substituted ketolide derivatives |
| 05/20/2008 | CA2305619C Novel glycosaminoglycan and pharmaceutical composition using the same as active ingredient |
| 05/20/2008 | CA2294480C Microdose therapy of female sexual dysfunction by no, co, and their donors |
| 05/20/2008 | CA2269089C Sodium salt of [poly-(2,5-dihydroxyphenylene)]-4-thiosulphuric acid of linear structure as regulator of cell metabolism and production method thereof |
| 05/20/2008 | CA2268886C Aminothiophenecarboxamides |
| 05/20/2008 | CA2268257C Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid |
| 05/20/2008 | CA2257841C Medicinal aerosol formulations of formoterol |
| 05/20/2008 | CA2231971C Hypolipidemic 1,4-benzothiazepine-1,1-dioxides |
| 05/20/2008 | CA2229202C Methods for identifying antagonist or agonist to human opioid receptor-like 1 "orl1" |
| 05/20/2008 | CA2223510C Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| 05/20/2008 | CA2214685C Benzamidine derivatives their preparation and their use as anti-coagulants |
| 05/20/2008 | CA2205664C Indole derivatives and medicinal use thereof |
| 05/20/2008 | CA2199664C Novel prodrugs for the therapy of tumors and inflammatory disorders |
| 05/20/2008 | CA2177695C Method of transmitting a biologically active material to a cell |
| 05/20/2008 | CA2169695C Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations and medicaments containing them |
| 05/20/2008 | CA2169694C Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 05/20/2008 | CA2169621C Use of oligosaccharides for the prevention and treatment of tissue ageing |
| 05/20/2008 | CA2159610C Prodrugs with enhanced penetration into cells |
| 05/17/2008 | CA2618240A1 Sustained-release formulations of topiramate |
| 05/17/2008 | CA2610652A1 Extended release compositions and methods for their manufacture |
| 05/15/2008 | WO2008058287A1 COMBINATION OF ERα+ LIGANDS AND HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF CANCER |
| 05/15/2008 | WO2008058285A2 4-cyanophenylamino-substituted bicyclic heterocyclic compounds as hiv inhibitors |
| 05/15/2008 | WO2008058278A2 POLYMORPHS OF N2-(1, 1' - BIPHENYL - 4 - YLCARBONYL) - N1- [2- (4 - FLUOROPHENYL) -1, 1 - DIMETHYLETHYL]- L - α -GLUTAMINE |
| 05/15/2008 | WO2008058229A1 Pyridinone compounds |
| 05/15/2008 | WO2008058225A2 Methods and compositions for treating cancer using bcl-2 antisense oligomers, tyrosine kinase inhibitors, and chemotherapeutic agents |
| 05/15/2008 | WO2008058220A2 Transdermal drug delivery system |
| 05/15/2008 | WO2008058206A2 System and method for treating a fluid |
| 05/15/2008 | WO2008058178A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 05/15/2008 | WO2008058167A2 Method for treating disorders associated with complement activation |
| 05/15/2008 | WO2008058126A2 Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors |
| 05/15/2008 | WO2008058098A2 Method of treating asthma, allergic rhinitis, and skin disorders |
| 05/15/2008 | WO2008058068A1 (r)-phenyl(heterocycle)methanol-based compounds, compositions comprising them and methods of their use |
| 05/15/2008 | WO2008058064A1 Amine-linked multicyclic compounds as inhibitors of the proline transporter |
| 05/15/2008 | WO2008058037A1 Compounds and compositions as protein kinase inhibitors |